Skip to content

Clinical trials

Phase 4 Hyperphosphatemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperphosphatemia Phase: Phase 4 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20072
20101
20121
20142
20151
20161
20173
20191
20202
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ardelyx2
Winthrop University Hospital2
Ain Shams University1
Assiut University1
Chugai Pharma Taiwan1
Fresenius Medical Care North America1
Jiujiang No.1 People's Hospital1
Kaiser Permanente1
Nabi Biopharmaceuticals1
Osaka University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperphosphatemia18
Kidney Failure, Chronic4
Renal Insufficiency4
Renal Insufficiency, Chronic4
Hyperparathyroidism, Secondary3
Hypercalcemia2
Kidney Diseases2
Anemia, Iron-Deficiency1
Arteriosclerosis1
Bone Diseases, Metabolic1

Trials

Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.